Predicting Response to Atomoxetine and Methylphenidate

ID Number
03-0612

The purpose of this study is three-fold. First, to compare the efficacy of four to five weeks of treatment with methylphenidate (Concerta™) and atomoxetine (Strattera™) on ADHD symptoms and associated functional impairment. Second, to evaluate differences in adverse effects and palatability between the two treatments. Third, to evaluate clinical and pharmacogenetic moderators of response to the two treatments.